Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis | |
Tan, Qiaoyun; Liu, Shuxia; Liang, Caixia; Han, Xiaohong; Shi, Yuankai | |
2018 | |
卷号 | 9期号:10页码:1220-1230 |
关键词 | Cancer immune checkpoint inhibitor marker neutrophil to lymphocyte ratio platelet to lymphocyte ratio |
ISSN号 | 1759-7706 |
DOI | 10.1111/1759-7714.12815 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6355679 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Tan, Qiaoyun,Liu, Shuxia,Liang, Caixia,et al. Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis[J],2018,9(10):1220-1230. |
APA | Tan, Qiaoyun,Liu, Shuxia,Liang, Caixia,Han, Xiaohong,&Shi, Yuankai.(2018).Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis.,9(10),1220-1230. |
MLA | Tan, Qiaoyun,et al."Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis".9.10(2018):1220-1230. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论